Latest News

Worldwide Study Unlocks Genetic Secrets of Gray Matter

Worldwide Study Unlocks Genetic Secrets of Gray Matter

A major international collaboration co-led by UNC School of Medicine scientist Jason Stein, PhD, has produced the first genetic map of the cerebral cortex, identifying more than 300 genetic variants that influence cortical structure and play roles in psychiatric conditions.

Worldwide Study Unlocks Genetic Secrets of Gray Matter - Read More…

UNC Health and WakeMed Seek Donations of Masks, Other Critical Medical Supplies

UNC Health and WakeMed are asking community organizations, corporations and individuals to donate much-needed medical supplies to help protect workers and patients across their respective systems.

UNC Health and WakeMed Seek Donations of Masks, Other Critical Medical Supplies - Read More…

UNC Researchers Look to Next Generation Genetic Sequencing for Deeper Understanding of COVID-19

UNC Researchers Look to Next Generation Genetic Sequencing for Deeper Understanding of COVID-19

Dirk Dittmer, PhD, professor of microbiology and immunology, is working with colleagues to explore how next generation sequencing can be used to help ensure accuracy in novel coronavirus diagnostics, as well as identify mutations and learn the history of the virus by sequencing its genome.

UNC Researchers Look to Next Generation Genetic Sequencing for Deeper Understanding of COVID-19 - Read More…

Match Day 2020 for UNC SOM Students

Match Day 2020 for UNC SOM Students

Today 165 UNC School of Medicine students found out where they will be going to complete their residency training.

Match Day 2020 for UNC SOM Students - Read More…

AskBio, UNC-Chapel Hill Collaborate on Angelman Syndrome Gene Therapy Research

AskBio, UNC-Chapel Hill Collaborate on Angelman Syndrome Gene Therapy Research

A UNC School of Medicine research team led by Mark Zylka, PhD, and Ben Philpot, PhD, has generated preclinical evidence that gene therapy may help individuals with Angelman syndrome by improving seizure and motor outcomes.

AskBio, UNC-Chapel Hill Collaborate on Angelman Syndrome Gene Therapy Research - Read More…

UNC School of Medicine Ranked First for Primary Care for Third Straight Year

UNC School of Medicine Ranked First for Primary Care for Third Straight Year

In the organization’s annual rankings of “America’s Best Graduate Schools,” U.S. News & World Report ranked UNC School of Medicine 1st in primary care and 23rd in research.

UNC School of Medicine Ranked First for Primary Care for Third Straight Year - Read More…

UNC Health Begins COVID-19 Testing at UNC Medical Center

UNC Health’s in-house testing will help ease demand on State Health Department & LabCorp.

UNC Health Begins COVID-19 Testing at UNC Medical Center - Read More…

Newer Anti-HIV Drugs Safest, Most Effective During Pregnancy

Newer Anti-HIV Drugs Safest, Most Effective During Pregnancy

Dolutegravir-containing regimen exhibited superior safety profile in large, NIH-supported study of pregnant women. UNC’s Lameck Chinula presented findings at the online Conference on Retroviruses and Opportunistic Infections. UNC’s Jeffrey Stringer is a study investigator.

Newer Anti-HIV Drugs Safest, Most Effective During Pregnancy - Read More…

Virtual Reality Shows Promise for Early Detection of MS Balance Problems

Virtual Reality Shows Promise for Early Detection of MS Balance Problems

The UNC School of Medicine lab of Jason Franz, PhD, created virtual reality experiments to show how a potentially portable and inexpensive test could reduce falls and related injuries in people with multiple sclerosis.

Virtual Reality Shows Promise for Early Detection of MS Balance Problems - Read More…

Scientists Create Tool to Detect Genes Associated with Psychiatric, Neurodegenerative Diseases

Scientists Create Tool to Detect Genes Associated with Psychiatric, Neurodegenerative Diseases

Led by UNC School of Medicine neuroscientist Hyejung Won, PhD, researchers created H-MAGMA, a computational tool that improves current technology used to link non-coding genetic variants to the genes associated with diseases through genome-wide association studies.

Scientists Create Tool to Detect Genes Associated with Psychiatric, Neurodegenerative Diseases - Read More…

ViiV Healthcare, UNC-Chapel Hill announce five-year, $20 million renewal of HIV cure partnership

ViiV Healthcare, UNC-Chapel Hill announce five-year, $20 million renewal of HIV cure partnership

This unique public-private collaboration provides funding for HIV Cure Center and Qura Therapeutics, the joint venture that brings academic and pharmaceutical research scientists together for the goal of curing people with HIV. David Margolis, MD, is the director of the UNC Cure Center.

ViiV Healthcare, UNC-Chapel Hill announce five-year, $20 million renewal of HIV cure partnership - Read More…

CAR-T immunotherapy for lymphoma studied at UNC Lineberger receives fast-track designation from FDA

CAR-T immunotherapy for lymphoma studied at UNC Lineberger receives fast-track designation from FDA

Based on proof-of-concept results from clinical trials at UNC Lineberger Comprehensive Cancer Center and Baylor College of Medicine, an investigational cellular immunotherapy for Hodgkin lymphoma has received a Regenerative Medicine Advanced Therapy designation from the U.S. Food and Drug Administration.

CAR-T immunotherapy for lymphoma studied at UNC Lineberger receives fast-track designation from FDA - Read More…

North Carolina’s Early Check Program to Add New Muscular Dystrophy Test to Newborn Screening Panel

North Carolina’s Early Check Program to Add New Muscular Dystrophy Test to Newborn Screening Panel

The test will identify Duchenne muscular dystrophy and some other types of muscle conditions, as part of the Early Check Program, which is led at UNC-Chapel Hill by Cynthia Powell, MD.

North Carolina’s Early Check Program to Add New Muscular Dystrophy Test to Newborn Screening Panel - Read More…

Five-year survival improves for certain cancers in adolescents and young adults

Five-year survival improves for certain cancers in adolescents and young adults

UNC Lineberger's Hazel Nichols, PhD, is senior author of a report in the Journal of the National Cancer Institute that shows which cancer types saw improved outcomes among adolescents and young adults.

Five-year survival improves for certain cancers in adolescents and young adults - Read More…

CAR-T therapy gives patient options after cancer returns

CAR-T therapy gives patient options after cancer returns

When Sabrina Shelton exhausted traditional treatment options, her care team at UVA referred her to UNC Lineberger’s Matthew Foster, MD, for a chimeric antigen receptor T-cell (CAR-T) therapy clinical trial. Watch the video and read the story about her journey.

CAR-T therapy gives patient options after cancer returns - Read More…